[1]
Sanmati K. Jain et al. 2021. Isatin Derivatives as Human Intestinal Carboxylesterase Inhibitors: An Approach towards 3D-QSAR, Pharmacophore and Molecular Docking. Current Aspects in Pharmaceutical Research and Development Vol. 2. (Sep. 2021), 1–21. DOI:https://doi.org/10.9734/bpi/caprd/v2/12980D.